Enjoy complimentary customisation on priority with our Enterprise License!
The intrauterine contraceptive devices (IUD) market size is forecast to increase by USD 1.11 billion at a CAGR of 4.36% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The increasing rate of unintended pregnancies and unwanted abortions globally is driving demand for long-term, effective contraceptive solutions like IUDs. IUDs offer long-term efficacy and increased acceptance among women due to their convenience and effectiveness in preventing pregnancies for extended periods. However, the market also faces challenges, including the adverse effects associated with IUD use, such as heavy menstrual bleeding, cramping, and potential perforation. They are superior to copper intrauterine devices and pose fewer complications and risks. Although the online segment has a smaller share of the market, it is expected to grow faster than the offline segment, thanks to increased Internet connectivity, mobile adoption, and consumer awareness. Addressing these concerns through continuous research and development of new IUD technologies is crucial for market expansion. Additionally, increasing awareness and education about the benefits and risks of IUDs, as well as efforts to make them more accessible and affordable, will further fuel market growth.
_market_size_abstract_2024_v1.jpg.webp?v4.1.18)
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbvie - The company offers intrauterine contraceptive devices such as the LILETTA (levonorgestrel-releasing) intrauterine contraceptive. Also, the company undertakes the research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve established long-term strategic goals.
The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market players, including:
Technavio’s report consists of a holistic analysis of the key development analysis, development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.
The intrauterine devices market share growth by the hormonal intrauterine device segment will be significant during the forecast period. Hormonal intrauterine device are more effective in preventing pregnancies when compared with other contraception devices.
_market_segments_abstract_2024_v2.jpg.webp?v4.1.18)
Get a glance at the market contribution of various segments Download PDF Sample
The hormonal intrauterine device segment accounted for USD 3.13 billion in 2018 and showed a gradual increase during the forecast period. Moreover, advances in hormonal intrauterine devices provide additional benefits with 100% efficacy against pregnancy. As hormonal intrauterine device can last 3-5 years, they are termed long-term reversible birth control. These factors of the hormonal intrauterine device will drive the market growth during the forecast period.
_market_regions_abstract_2023_geo_v2.jpg.webp?v4.1.18)
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Technological innovations such as postpartum will facilitate the intrauterine devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for companies, which will assist in creating efficient business plans. Hence, such factors are driving the market in North America during the forecast period.
In discussions surrounding reproductive health, topics such as premarital relationships, unplanned pregnancy, and the subsequent discontinuation of schooling often arise. Access to abortion services at hospitals or clinics is crucial for individuals facing such circumstances. Family planning initiatives aim to address the high prevalence of unplanned pregnancies by providing contraceptives and promoting affordability. Current trends and estimations suggest a growing demand for accessible reproductive healthcare solutions. Additionally, advancements in prostaglandins and hormones offer alternative methods for contraception. Community healthcare programs play a vital role in distributing these resources and educating individuals about their options. Collaborative efforts between organizations like Gates Open Research and healthcare providers ensure continuous progress in reproductive health, addressing challenges such as white blood cells and optimizing fertility treatments. Adolescent sexual activity necessitates awareness of contraception methods to prevent unintended pregnancies, considering the role of sperm, egg, and children.
The market has seen growth due to the increasing popularity of online sales channels, which provide vendors with increased visibility and reduced inventory management costs. Although the online segment has a smaller share of the market, it is expected to grow faster than the offline segment, thanks to increased Internet connectivity, mobile adoption, and consumer awareness.
Moreover, the vendors can gain higher revenue through e-commerce, and consumers can access healthcare and wellness updates through social media platforms. Consumers' trust in online sales and fast-shipping services has contributed to the growth in IUD sales through online channels. The convenience of purchasing IUD online is expected to drive market growth during the forecast period.
The IUD has evolved in shape, size, and form over the years. Early designs, such as the Lippes Loop, Margulies Spiral, and Birnberg Bow, were followed by the problematic Dalkon Shield. Advances in the 1980s led to the development of reliable copper and T-shaped IUDs. Modern IUDs, such as PARAGARD, Mirena, and LILETTA, are effective and convenient, with low risks of side effects and ectopic pregnancy.
Moreover, technological advancements have increased IUD use among adolescents and nulliparous women, who are at a higher risk of unintended pregnancies. Therefore, such advancements will drive the growth of the global market in the forecast period.
The absence of insurance coverage for LARC device placement postpartum serves as a barrier to the adoption of IUDs. Pregnant women often lose coverage at sixty days postpartum, making it difficult for them to afford the procedure. Medicaid programs and most private insurers do not reimburse for device and placement procedures covered in outpatient clinical visits, nor do they cover the global fee for deliveries if placed immediately postpartum in the hospital.
However, the efforts have been made by state and federal agencies and healthcare officials to encourage payers to revise the reimbursement systems for immediate postpartum LARC. However, there is still a lack of reimbursement for IUDs, which could hinder the growth of the global market during the forecast period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
_market_customer_landscape_abstract_2023_geo_v1.jpg.webp?v4.1.18)
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The introduction of the T-shaped birth control device has contributed significantly to reproductive health initiatives, leading to an increase in awareness and providing a viable solution for individuals, including adolescents engaging in sexual activity. Access to such devices through community health care centers and ambulatory surgical centers has been facilitated by favorable regulatory scenarios. Both non-hormonal and hormonal devices are available to cater to diverse needs and preferences. However, profit-oriented business decisions within the supplier-buyer network can sometimes hinder accessibility. Despite this, efforts to educate about contraceptive options and promote healthcare infrastructure are ongoing to address challenges such as unsafe abortion and complications like bleeding and pain associated with inadequate access. Novel strategies are continuously being explored to overcome obstacles like lack of awareness and ensure the well-being of women, particularly concerning the positioning and efficacy of these devices within a woman's uterus.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
161 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.36% |
|
Market growth 2024-2028 |
USD 1.11 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.11 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key countries |
US, Germany, China, France, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd., Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.